Autoimmune-induced glutamatergic receptor dysfunctions: Conceptual and psychiatric practice implications
Authors:
- Andrea R. DurrantADAndrea R. Durrant
- Uriel Heresco-LevyUHUriel Heresco-Levy
- 1 December 2013
- journal article
- review article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 23 (12) , 1659-1671
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitisThe Lancet Neurology, 2011
- Disease-relevant autoantibodies in first episode schizophreniaJournal of Neurology, 2010
- High dose D-serine in the treatment of schizophreniaSchizophrenia Research, 2010
- Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2009
- Anti–N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis in children and adolescentsAnnals of Neurology, 2009
- AMPA receptor antibodies in limbic encephalitis alter synaptic receptor locationAnnals of Neurology, 2009
- Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodiesThe Lancet Neurology, 2008
- Paraneoplastic syndromes of the CNSThe Lancet Neurology, 2008
- A patient with encephalitis associated with NMDA receptor antibodiesNature Clinical Practice Neurology, 2007
- Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratomaAnnals of Neurology, 2007